EKO International Corp – CORRECTION – NeuroVasc Clinical Inc. to supply FREMS to first clinic.
Sep 28, 2012
OTC Disclosure News Service
Burlington, ONT, Canada –
EKO wishes to clarify a news release made yesterday.The company announced its affiliation and agreement with the Mayer Institute in Hamilton and Dr. Perry Mayer. It appears that the spelling of both the Mayer Institute and Dr. Perry Mayer was, in the transfer from the company to the news wire services, misspelled as “Meyer”. EKO apologizes for any confusion caused and wishes to assure the readers of this release that its the Mayer Institute in Hamilton Ontario, which first opened in 2008, which provides advanced diabetic foot and wound care (which it compliments with aggressive, ongoing diabetic education), with which its JV partner NeuroVasc Clinical Inc. has an agreement to provide FREMS machines, supplies,training and operational certification. More information on the co-operation and resource enhancement as between the Mayer Institute and NeuroVasc Clinical Inc. will be released in the coming weeks.
This press release contains forward-looking statements that reflect the Company’s current expectation regarding future events. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by EKO International (“The Company”) are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond the Company’s control and which could, and likely will, materially affect actual results, levels of activity,performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to up date the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company’s expectations include, but are not limited to,those factors that are disclosed under the heading “Risk Factors” and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities.
To contact the company by e-mail, please use firstname.lastname@example.org
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.